News | January 05, 2015

ProCure Proton Therapy Center in New Jersey Celebrates 1,000th Patient

Major milestone marks greater access to proton therapy both locally and abroad

January 5, 2015 — Zelina Amir was the 1,000th patient to complete treatment at the ProCure Proton Therapy Center in Somerset, New Jersey. Amir, who traveled to ProCure from Israel, was treated for a hemangioblastoma of the spine.

Proton therapy is a precise form of radiation that directly attacks tumors while minimizing potentially damaging radiation to surrounding healthy tissues and organs, and is beneficial for difficult-to-reach tumors and complex cases.

After getting in a car accident in 2006, a CT scan found a small tumor in Amir's spine, but it was recommended at that time that it not be treated by any means due to its sensitive location. In 2011, Amir was diagnosed with breast cancer, and it was then discovered that her hemangioblastoma tumor had grown larger and now mandated treatment. Since 2012, Amir has had five surgeries on her spine, only for the tumor to grow back. Amir’s doctors in Israel told her about proton therapy and ProCure, feeling strongly that it was the key to her recovery.

Studies have shown proton therapy to be effective in treating many types of cancers, including tumors of the brain, gastrointestinal system, head and neck region and prostate, as well as sarcomas and most pediatric cancers. The precision of proton therapy makes it especially effective for treating children and adults with anatomically complex tumors, such as tumors that are inoperable, located at the base of the skull, or along the spinal cord.

For more information: www.procure.com

 

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...
Netherlands Proton Therapy Center Delivers First Clinical Flash Irradiation
News | Proton Therapy | May 02, 2019
IBA (Ion Beam Applications SA) recently announced the first Flash irradiation in an IBA proton therapy gantry treatment...
Pencil Beam Scanning Better Protects Children With Brain Tumors
News | Proton Therapy | May 01, 2019
A comparison of three types of radiotherapy for children's brain tumors suggests a type of proton therapy called pencil...
California Protons Cancer Therapy Center Begins Breast Cancer Study Enrollment
News | Proton Therapy | April 25, 2019
California Protons Cancer Therapy Center announced two major efforts representing significant steps forward in breast...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
ZON-PTC in Clinical Use With RayStation 8B and Hyperscan
News | Treatment Planning | March 19, 2019
Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated its first patient...
What to Expect from the Proton Therapy Market in 2019-2020
News | Proton Therapy | March 13, 2019
The number of new particle therapy rooms ordered worldwide dropped by almost 20 percent in 2018, according to a new...
Videos | Proton Therapy | March 01, 2019
ITN Associate Editor Jeff Zagoudis speaks with Mark Pankuch, Ph.D., director of physics and dosimetry at the...
Videos | Proton Therapy | February 28, 2019
ITN Associate Editor Jeff Zagoudis speaks with ...